glp 1 drugs how long have they been around Chart: in 8 Americans Now Use GLP-1 for Weight Loss GLP-1s were first approved in

6 Department of Diabetes and Endocrinology, Birmingham Heartlands Hospital, Birmingham, UK Correspondence: Konstantinos A Toulis Department of Endocrinology, Diabetes and Metabolism, 424 General Military Hospital, Thessaloniki, Greece Tel +30 231 038 1902 Email [email protected] *These authors contributed equally to this work Abstract: Glucagon-like peptide 1 receptor agonists (GLP1-RA) are prominent agents in the therapeutics of type 2 diabetes mellitus due to their exemplary efficacy in both preprandial and postprandial glycemia, their safety, low risk of hypoglycemia, their multilevel pathophysiological superiority, weight loss and importantly the observed benefits in cardiovascular disease reduction

Semaglutide is not a reportable compound in this system, regardless of how frequently you test positive random selection

Strategies such as reducing costs, expanding insurance coverage, and improving cultural competency among healthcare providers should generally be strived for, with the aim of a more inclusive and fair healthcare system

Again, nothing in this expanded list has any relationship to GLP-1 medications

Its worth noting the first GLP-1 receptor agonist approved for the treatment of type 2 diabetes was Byetta (exenatide), which received approval, over 20 years ago, in 2005

I would love to see what the out of pocket cost for patients are